Topic: healthcare

Lawsuit Filed by 25 States Against Trump Administration Over Federal Student Loan Caps Amid Nursing Shortage Concerns

05/21/2026, 03:15 PM business announcement healthcare

A coalition of 25 states and the District of Columbia has filed a lawsuit against the Trump administration over new federal student loan limits, which could exacerbate the nursing shortage as students in healthcare fields face increased financial barriers to education.

Eli Lilly’s Next-Generation Weight Loss Drug Retatrutide Successfully Completes Key Obesity Trial

05/21/2026, 11:33 AM business research healthcare

Eli Lilly's retatrutide has successfully passed a late-stage trial for obesity treatment, showing significant weight loss results that could enhance its competitive position in the growing weight loss and diabetes drug market.

Shares of German prosthetics firm Ottobock (OTB) drop over 10% amid allegations from hedge fund Grizzly Research

05/19/2026, 04:33 PM stock_drop healthcare

Ottobock's shares dropped over 10% following allegations from Grizzly Research, a U.S. hedge fund, claiming the company's majority shareholder misappropriated funds and supported Russian military efforts. This situation raises concerns about the company's financial practices and its exposure to the Russian market.

Novo Nordisk Plans Global Launch of Wegovy Pill Amidst Competitive Weight-Loss Market

05/18/2026, 05:33 AM announcement healthcare

Novo Nordisk has told CNBC how it is preparing to go "all in" on launching its Wegovy pill outside the U.S, as the battle for dominance of the weight-loss market goes global.

Johnson & Johnson’s New Psoriasis Pill Icotyde Aims to Become a Major Revenue Driver Amid Market Challenges

05/16/2026, 12:32 PM growth healthcare

Johnson & Johnson is banking on its newly launched psoriasis medication, Icotyde, to significantly boost its revenue.

Biogen Advances Alzheimer’s Drug Diranersen to Late-Stage Trials Despite Mixed Mid-Stage Results

05/14/2026, 04:31 PM business announcement healthcare

Biogen has announced its decision to advance an experimental Alzheimer's drug, Diranersen, into late-stage Phase 3 testing despite disappointing results from mid-stage trials.

Novo Nordisk Reports High-Dose Wegovy Achieves Nearly 28% Weight Loss in Some Patients

05/12/2026, 02:33 PM business research healthcare

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox.

Hims & Hers (HIMS) Shares Drop 15% Following First-Quarter Loss and Weak Earnings Guidance

05/12/2026, 12:34 PM stock_drop healthcare

Hims & Hers, a telehealth company, experienced a significant decline in its stock price, dropping 15.5% in premarket trading following the release of its first-quarter earnings report.

First Generic Versions of Novo Nordisk’s Ozempic Approved in Canada, Testing Market Dynamics

05/10/2026, 08:07 PM business review healthcare

Health Canada has approved the first generic versions of Novo Nordisk's diabetes drug Ozempic, with Indian drugmaker Dr.

Ultragenyx Hosts Rare Bootcamp to Empower Families in Drug Development for Rare Diseases

05/10/2026, 08:07 PM business announcement healthcare

Developing a new drug can cost a billion dollars and take more than a decade.